skip to main content

H.R. 3504 (104th): Breast Cancer Detection Act

The text of the bill below is as of May 22, 1996 (Introduced).


HR 3504 IH

104th CONGRESS

2d Session

H. R. 3504

To authorize the marketing of breast examination pads without restriction.

IN THE HOUSE OF REPRESENTATIVES

MAY 22, 1996

Mrs. VUCANOVICH (for herself, Mr. BAKER of California, Mr. BARTON of Texas, Mr. BURR, Mr. MYERS of Indiana, and Mr. POSHARD) introduced the following bill; which was referred to the Committee on Commerce


A BILL

To authorize the marketing of breast examination pads without restriction.

    Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ‘Breast Cancer Detection Act’.

SEC. 2. FINDINGS.

    The Congress finds the following:

      (1) Breast cancer is the second leading cause of death by cancer in women.

      (2) An estimated 184,300 new invasive cases of breast cancer in the United States are expected in 1996.

      (3) An estimated 44,300 women are expected to die of breast cancer during 1996.

      (4) While there is no cure for breast cancer, early detection is the key to survival of this devastating disease.

      (5) The 3 point breast cancer detection plan recommended by the National Cancer Institute includes mammography, physical breast examination, and a breast self-examination.

      (6) The National Cancer Institute recommends that women do a breast self-examination on a monthly basis.

      (7) The Food and Drug Administration has recently made available a plastic pad to aid in self-examination of the breasts and to be used in addition to a bare hand self-examination.

      (8) The Congress believes that such a pad should be directly available to women.

SEC. 3. AIDS FOR SELF-EXAMINATION OF BREASTS.

    In the administration of approvals under chapter V of the Federal Food, Drug, and Cosmetic Act of devices to aid in the self-examination of breasts, the Secretary of Health and Human Services shall approve the marketing of such devices without the requirement under section 520(e) of such Act that such devices be restricted to sale, distribution, or use only upon a prescription of a licensed practitioner or otherwise be restricted in their availability to women.